Description of the medicine: Ubinon (Ubinonum)
KILLING (Ubinonum). 6-decaprenyl-2, 3-dimethoxy-5-methyl-1, 4-benzoquinone.
Synonyms: Coenzyme Q, Ko Q, Ubiquinone, Adelir, Coenzym Q, Emitolon, Inokiten, Parbinon, Sempinon, Senon, Terekol, Tridemin, Ubequinon, Ubidecarenone, Ubifactor, Ubirecanone, Ubiten, Udekinon, Yubekon, etc.
Ubiquinone is a coenzyme widely distributed in the cells of the body. It is a carrier of hydrogen ions, a component of the respiratory chain. Chemically, it is a derivative of benzoquinone.
For medical use, get synthetically.
As a medicine, it is used as an antioxidant that can inhibit lipid peroxidation processes (see Tocopherol acetate, Dibunol) and have an antihypoxic effect.
The main application is in the complex treatment of patients with coronary heart disease, with myocardial infarction. It was noted that when using the drug, the clinical course of the disease improves, tolerance to physical activity increases, the content of prostacyclin in the blood increases and the content of thromboxane decreases. Ubinon is also prescribed to athletes to restore performance.
Assign to adults inside (regardless of the time of eating) for therapeutic purposes, 0.03 g (2 capsules) 3 times a day. The course of treatment is 1 to 3 months. Athletes are prescribed 0.045 g 2 to 3 times a day for 7 to 10 days.
The drug is usually well tolerated. In some cases, nausea, upset stools are possible; then stop taking the drug.
Release form: in capsules of 0.015 g in the form of a solution in oil.
Storage: in a dry, dark place at room temperature.